A clinical trial of MK-6050 in healthy participants (MK-6050-002)
MK-6050-002
Phase 1 other active
Quick answer
A clinical trial of MK-6050 in healthy participants (MK-6050-002) for Hidradenitis suppurativa is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Hidradenitis suppurativa
- Phase
- Phase 1
- Modality
- other
- Status
- active